Table 2.
Biochemical variables and cardiac and renal hypertrophies at the end of the three-week treatment period (mean ± SE, n = 6–9).
| Variable | Control | Fermented milk | Peptide | Difference between the groups, P |
|---|---|---|---|---|
| Urinary albumin, mg/d | 22 ± 4 | 35 ± 8 | 30 ± 4 | .20 |
| PRA, ng Ang I/mL/h | 90 ± 17 | 99 ± 30 | 95 ± 19 | .98 |
| BNP, pmol/L | 3.1 ± 0.5 | 2.3 ± 0.2 | 3.5 ± 0.3 | .24 |
| Aldosterone, pg/mL | 1228 ± 302 | 2551 ± 921 | 1494 ±218 | .18 |
| Cardiac hypertrophy index (mg/g) | 5.3 ± 0 | 5.1 ± 0 | 5.1 ± 0 | .59 |
| Renal hypertrophy index (mg/g) | 4.6 ± 0 | 4.8 ± 0 | 4.8 ± 0 | .61 |